Skip to main content
DONGSUNG PHARMACEUTICAL CO.,LTD logo

DONGSUNG PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002210 ISIN · KR7002210003 KO Manufacturing
Open in API
Filings indexed 383 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country KR South Korea
Listing KO 002210

About DONGSUNG PHARMACEUTICAL CO.,LTD

http://dongsung-pharm.com/user-english/

Dongsung Pharmaceutical Co., Ltd., established in 1957, develops, manufactures, and markets a diverse range of products across pharmaceuticals, cosmetics, and hair care. The company's pharmaceutical division produces over-the-counter (OTC) drugs and is expanding into health functional foods. Its portfolio also includes a variety of cosmetic products and is particularly known for its hair dyes. Dongsung Pharmaceutical focuses on developing nature-friendly products and is engaged in advanced research, including photodynamic therapy (PDT) for potential cancer treatments.

Recent filings

Filing Released Lang Actions
기타시장안내 (개선계획 이행 여부 심의 요청)
Regulatory Filings Classification · 87% confidence The document is a Korean Exchange (“KRX”) listing notification titled “기타시장안내” indicating the company submitted its improvement plan implementation details for review by the Exchange’s corporate review committee. It is not an actual financial report (e.g., annual or interim) but a regulatory market notice. Therefore, it falls under “Regulatory Filings” (RNS).
2026-05-22 Korean
기타안내사항(안내공시)
Regulatory Filings Classification · 85% confidence The document is a short regulatory notice (“기타 안내사항(안내공시)”) in Korean announcing the expiration of the lock-up/mandatory holding period for certain shares following the company’s IPO. It contains no financial statements or detailed analysis, nor does it report a share buyback, dividend, voting results, or management changes. It is a general compliance announcement without fitting into specific categories like share issue, repurchase, or financial reporting. Therefore, it falls under the fallback “Regulatory Filings” category (RNS).
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 99% confidence The document is titled “분기보고서” with specific quarterly period dates (2026-01-01 to 2026-03-31) and contains detailed financial statements, business overview, notes, and audit opinions. It is clearly an interim/quarterly report containing substantive financial data for a period shorter than a full fiscal year. Therefore, it should be classified as an Interim / Quarterly Report. Q1 2026
2026-05-15 Korean
소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 90% confidence The document is a corporate disclosure detailing the filing of a lawsuit (손해배상 청구의 소) against the company, including case name, plaintiff, claim amount, jurisdiction, and legal strategy. This is a clear update on a significant legal proceeding, matching the “Legal Proceedings Report” category.
2026-05-15 Korean
회생절차종결결정
Legal Proceedings Report Classification · 90% confidence The document is an official court decision regarding the termination (‘종결결정’) of corporate rehabilitation proceedings for 동성제약. It references a legal case number, court name, decision date, legal basis (Debtor Rehabilitation and Bankruptcy Act), and outlines factual and legal reasons. This fits the definition of a Legal Proceedings Report (LTR), which covers updates on significant lawsuits, regulatory or legal actions.
2026-05-15 Korean
[기재정정]주주총회소집결의
Regulatory Filings Classification · 95% confidence The document is a Korean regulatory disclosure announcing and correcting a board resolution to convene an extraordinary shareholders’ meeting (“주주총회소집결의”). It does not contain full financial statements, proxy cards, or an investor presentation. It is an official corporate filing announcing meeting convening details rather than the meeting minutes or voting results. This falls under the general “Regulatory Filings” category (RNS).
2026-05-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.